论文部分内容阅读
《中国中医药报》2014年12月8日讯:2014年12月4日,江苏省中医院、江苏苏中药业集团与法国巴黎公立医院集团在南京签署“关于中法合作开展黄葵胶囊治疗糖尿病肾病蛋白尿的临床研究”协议,并为“国家中医药临床研究基地·中法中医药临床合作研究中心”揭牌,这标志着中法中医药合作进入了新阶段。2014年是中法建交50周年,为促进两国中医药学术领域的合作交流,以双方签约为契机,江苏省中医院还举办了中西医结合肾脏病国际论坛。论坛上,来自法国、美国、加拿大、日本、中国香港等国家和地区的20余
December 4, 2014: On December 4, 2014, Jiangsu Traditional Chinese Medicine Hospital, Jiangsu Suzhong Pharmaceutical Group and Paris Public Hospital Group of France signed the Letter of Agreement on the Cooperation between China and France on Huang Kui Capsule for the treatment of diabetic nephropathy proteinuria clinical research “agreement, and ” national clinical research base of traditional Chinese medicine, Sino-French clinical research center "inaugurated, which marks the Sino-French cooperation in traditional Chinese medicine has entered a new phase. 2014 marks the 50th anniversary of the establishment of diplomatic relations between China and France. To promote the cooperation and exchange between the two countries in the academic field of traditional Chinese medicine, with the signing of an agreement by both parties, the Jiangsu Provincial Hospital of Traditional Chinese Medicine held an international forum on Integrative Nephrology. Forum, from France, the United States, Canada, Japan, Hong Kong and other countries and regions more than 20